Clinical Trial Update: 2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ISV-305 to vehicle for inflammation and pain after cataract surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation and Pain Associated with Cataract Surgery

Drugs mentioned

• ISV-305

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Inflammation and Pain Associated With Cataract Surgery | Phase 3 | Status: COMPLETED | Results posted: 2021-01-11